Stocktoria
Alignment Healthcare, Inc. ALHC
Alignment Healthcare, Inc. (ALHC) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $3.9B at a -0.0% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-05-26 | Barclays | Equal-Weight (main) |
| 2026-05-01 | UBS | Neutral (main) |
| 2026-05-01 | Barclays | Equal-Weight (main) |
| 2026-02-05 | JP Morgan | Overweight (main) |
| 2026-01-16 | TD Cowen | Buy (main) |
| 2026-01-14 | UBS | Neutral (main) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Finance, Insurance & Real Estate · percentile among 1129 companies
Percentile vs other Finance, Insurance & Real Estate companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 5/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.37 |
| Retained earnings / assets | -0.947 |
| EBIT / assets | 0.014 |
| Equity / liabilities | 0.202 |
Sector peers · similar-size Finance, Insurance & Real Estate companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| ALHC | Alignment Healthcare, Inc. | 5/9 | -0.35 | — | +46.1% |
| CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | 2/9 | -12.26 | — | +40.3% |
| TRUP | TRUPANION, INC. | 2/9 | 2.14 | — | +11.9% |
| OSCR | Oscar Health, Inc. | 4/9 | -2.18 | — | +27.5% |
| MOH | MOLINA HEALTHCARE, INC. | 4/9 | 3.6 | 25.4 | +11.7% |
| HUM | HUMANA INC | 5/9 | 5.1 | 38.8 | +10.1% |
| CNC | CENTENE CORP | 4/9 | 0.38 | — | +19.4% |
All Finance, Insurance & Real Estate companies →
About Alignment Healthcare, Inc.
Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans. Alignment Healthcare, Inc. was founded in 2013 and is based in Orange, California.
FAQ
Is ALHC financially healthy?
Alignment Healthcare, Inc.'s Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does ALHC pay a dividend?
No, Alignment Healthcare, Inc. does not currently pay a dividend.
How profitable is ALHC?
In FY2025, Alignment Healthcare, Inc. had a net margin of -0.0% and a return on equity of -0.4%.
What is the analyst price target for ALHC?
The average Wall-Street price target for Alignment Healthcare, Inc. is $24.92, about 84.3% above the recent price, from 13 analysts (consensus: strong buy).
Is ALHC a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Alignment Healthcare, Inc.: a Piotroski F-score of 5/9, an Altman Z″ in the distress zone. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.